Commentary
Commentary
Can HPV Vaccination Be Simplified?
Commentary
VA Adopts Innovative Project Nationwide
Commentary
Awareness Is Top Weapon Against Delirium
Commentary
Why Sick Residents Must ... Show ... Up ... at ... Work
Commentary
Is Tamoxifen Pharmacogenetics Clinically Relevant?
Commentary
2011 FDA Approvals
Conference Coverage
AACE: Does Diabetes Raise the Risk of Cancer?
Commentary
IOM Unveils Hot Reads in Time for Summer
Conference Coverage
Two Targeted Agents Best Chemotherapy in BRAF-Mutant Melanoma
Major Finding: Relative to chemotherapy, trametinib improved progression-free survival (hazard ratio, 0.45) and overall survival (HR, 0.54), and...